What is included in long-term monitoring of renal transitional cell carcinoma?

Updated: Nov 05, 2019
  • Author: Bagi RP Jana, MD, MBA, MHA, FACP; Chief Editor: E Jason Abel, MD  more...
  • Print
Answer

Because of the high risk of local and bladder recurrences, long-term follow-up care for these patients is mandatory. Include ureteroscopy, cystoscopy, and either IVU or RPG in the routine follow-up procedures.

Urine markers are used more and more frequently in the follow-up of patients with UCs. The specificity of these tests (eg, BTA Stat [Polymedco, Cortlandt Manor, NY], ImmunoCyt [Scimedx, Denville, NJ], and fluorescence in situ hybridization [FISH]) is acceptable for follow-up, and their sensitivity is much better than that of urine cytology.


Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!